Undertaking positive control studies as part of developmental neurotoxicity testing: a report from the ILSI Research

Kevin M Crofton1, John A Foss, Ulla Hass

  • 1Neurotoxicology Division, NHEERL, ORD, US EPA, Research Triangle Park, NC, USA. crofton.kevin@epa.gov

Insights

Positive control studies are essential for reliable developmental neurotoxicity (DNT) risk assessments. This review guides the selection and use of positive control agents to ensure accurate DNT testing and data interpretation.

Area of Science:

  • Toxicology
  • Neuroscience
  • Risk Assessment

Background:

  • Developmental neurotoxicity (DNT) testing requires robust positive control data.
  • Positive controls validate laboratory performance and the sensitivity of DNT assays.
  • These data support the biological significance of findings and confidence in negative results.

Purpose of the Study:

  • To provide a practical guide for selecting and using positive control agents in DNT studies.
  • To discuss the advantages and disadvantages of various positive control agents for DNT endpoints.
  • To offer recommendations for interpreting and reporting positive control data in DNT risk assessments.

Main Methods:

  • Review of existing literature on positive control agents in developmental neurotoxicology.
  • Analysis of advantages and disadvantages of different positive control agents for specific DNT endpoints.
  • Consideration of study design issues pertinent to positive control studies in DNT.

Main Results:

  • Positive control data are critical for evaluating laboratory capabilities in DNT testing.
  • They aid in determining the biological significance of observed effects and increase confidence in negative findings.
  • The review discusses agent selection based on DNT study endpoints and provides guidance on data interpretation.

Conclusions:

  • Positive control studies are an integral part of DNT testing and risk assessment.
  • Implementing standardized positive control studies enhances the reliability and validity of DNT data.
  • Laboratories generating data for risk decisions should incorporate positive control studies into their DNT testing protocols.

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...